Published in Curr Med Chem on January 01, 2015
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Nutrients (2015) 0.88
Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome. Int J Mol Sci (2016) 0.76
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study. Drug Des Devel Ther (2015) 0.76
Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review. Front Pharmacol (2017) 0.75
Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. Biomed Res Int (2017) 0.75
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97
The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med (2006) 4.67
Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA (2006) 4.08
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med (2009) 2.79
Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes (2004) 2.55
A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol (2004) 2.46
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42
Hemodynamic actions of insulin. Am J Physiol (1994) 2.23
Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes (2006) 2.14
Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol (2001) 2.03
Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab (2003) 1.88
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr (2008) 1.82
Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst (1994) 1.74
Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes (1997) 1.71
Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr (2008) 1.68
Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes (2002) 1.60
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol (2005) 1.60
EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab (2007) 1.58
Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem (2001) 1.58
Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes (2000) 1.58
Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr (2005) 1.57
Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem (2002) 1.56
Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. J Soc Gynecol Investig (2006) 1.56
Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab (2002) 1.56
Mixed meal and light exercise each recruit muscle capillaries in healthy humans. Am J Physiol Endocrinol Metab (2006) 1.52
A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) (2007) 1.50
Tea enhances insulin activity. J Agric Food Chem (2002) 1.43
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem (2007) 1.43
Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr (2006) 1.42
Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol (2004) 1.41
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res (2005) 1.35
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes (2002) 1.35
Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr (2008) 1.34
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr (2004) 1.32
Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes (2004) 1.31
Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr (2010) 1.31
Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem (2007) 1.28
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr (2008) 1.28
Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem (2004) 1.28
Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr (2009) 1.27
Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am J Physiol Endocrinol Metab (2007) 1.25
Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol (2002) 1.23
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res (2012) 1.23
Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr (2008) 1.22
Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr (2004) 1.21
Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab (Lond) (2012) 1.20
Effects of green tea on weight maintenance after body-weight loss. Br J Nutr (2004) 1.18
Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) (2005) 1.17
Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem (2003) 1.17
Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract (2005) 1.16
Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care (2009) 1.15
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol (2005) 1.11
Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res (2009) 1.11
Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) (2005) 1.10
A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) (2008) 1.10
Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care (2003) 1.07
Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis (1991) 1.05
Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother (2010) 1.03
Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res (2012) 1.03
Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol (2004) 1.03
Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. J Am Coll Nutr (2009) 1.03
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition (2010) 1.02
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev (2011) 1.01
Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr (2008) 1.01
Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metab Cardiovasc Dis (2014) 1.00
Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med (2009) 1.00
Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology (2009) 1.00
Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochem Biophys Res Commun (2008) 0.99
Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncol (1993) 0.98
Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr (2007) 0.98
Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med (2012) 0.97
Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes (1999) 0.95
Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet (2010) 0.95
Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. Br J Nutr (2008) 0.95
Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr J (2010) 0.94
Effects of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr (2008) 0.94
Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr (2011) 0.94
Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab (Lond) (2012) 0.93
Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS One (2012) 0.93
Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. Biofactors (2004) 0.93
Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease. Diabetes Res Clin Pract (2004) 0.93
Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion. J Biol Chem (2008) 0.91
Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction. Am J Physiol Endocrinol Metab (2013) 0.90
Loss of insulin-mediated microvascular perfusion in skeletal muscle is associated with the development of insulin resistance. Diabetes Obes Metab (2010) 0.90
Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss. Am J Clin Nutr (2009) 0.90
Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr (2008) 0.90
Metabolic effects of green tea and of phases of weight loss. Physiol Behav (2005) 0.89
The EGCg-induced redox-sensitive activation of endothelial nitric oxide synthase and relaxation are critically dependent on hydroxyl moieties. Biochem Biophys Res Commun (2010) 0.88
Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine (2009) 0.88
Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model. J Ethnopharmacol (2005) 0.88
Muscle insulin resistance resulting from impaired microvascular insulin sensitivity in Sprague Dawley rats. Cardiovasc Res (2013) 0.86
Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols. Eur J Nutr (2012) 0.86
Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol Endocrinol Metab (2013) 0.86
Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Diabetes (2006) 0.86
Epigallocatechin gallate increase the prostacyclin production of bovine aortic endothelial cells. Prostaglandins Other Lipid Mediat (2000) 0.85
Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo. Am J Physiol Endocrinol Metab (2013) 0.85
Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis (2012) 0.85
Point: There is capillary recruitment in active skeletal muscle during exercise. J Appl Physiol (1985) (2007) 9.48
Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes (2004) 2.55
Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab (2003) 1.71
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response. Leuk Res (2012) 1.60
EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab (2007) 1.58
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease. Acta Haematol (2015) 1.42
Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes (2002) 1.32
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension (2010) 1.32
Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes (2004) 1.31
Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes (2002) 1.26
The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev (2004) 1.26
Oxidative stress-induced JNK1/2 activation triggers proapoptotic signaling and apoptosis that leads to diabetic embryopathy. Diabetes (2012) 1.17
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. BMC Cancer (2010) 1.14
Two cases of thyroid storm-associated cholestatic jaundice. Endocr Pract (2007) 1.14
c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy. Diabetes (2012) 1.09
Age-related anabolic resistance after endurance-type exercise in healthy humans. FASEB J (2010) 1.09
Caspase-8: a key role in the pathogenesis of diabetic embryopathy. Birth Defects Res B Dev Reprod Toxicol (2009) 1.07
Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats. Diabetes (2007) 1.07
Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Am J Physiol Endocrinol Metab (2004) 1.06
Decreased microvascular vasomotion and myogenic response in rat skeletal muscle in association with acute insulin resistance. J Physiol (2009) 1.03
A new method to study changes in microvascular blood volume in muscle and adipose tissue: real-time imaging in humans and rat. Am J Physiol Heart Circ Physiol (2011) 1.01
SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent lipid peroxidation in diabetic embryopathy. Am J Obstet Gynecol (2011) 1.01
SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy. Am J Obstet Gynecol (2012) 1.00
Superoxide dismutase 1 overexpression in mice abolishes maternal diabetes-induced endoplasmic reticulum stress in diabetic embryopathy. Am J Obstet Gynecol (2013) 0.99
Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Arterioscler Thromb Vasc Biol (2010) 0.99
Trehalose prevents neural tube defects by correcting maternal diabetes-suppressed autophagy and neurogenesis. Am J Physiol Endocrinol Metab (2013) 0.98
A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle. Mol Ther (2004) 0.98
Active role for the vasculature in the delivery of insulin to skeletal muscle. Clin Exp Pharmacol Physiol (2005) 0.96
Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation (2012) 0.95
Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care (2006) 0.94
The microvasculature in insulin resistance and type 2 diabetes. Semin Vasc Med (2002) 0.94
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy. Int J Cancer (2011) 0.93
TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction. Am J Physiol Endocrinol Metab (2003) 0.93
Muscle perfusion: its measurement and role in metabolic regulation. Diabetes (2012) 0.92
Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. Am J Physiol Endocrinol Metab (2012) 0.92
Role of capsular polysaccharide (CPS) in biofilm formation and regulation of CPS production by quorum-sensing in Vibrio vulnificus. Mol Microbiol (2013) 0.91
PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem Biophys Res Commun (2006) 0.91
Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction. Am J Physiol Endocrinol Metab (2013) 0.90
Graded occlusion of perfused rat muscle vasculature decreases insulin action. Clin Sci (Lond) (2007) 0.90
Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients. Eur Heart J (2007) 0.88
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res Treat (2015) 0.86
Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J Korean Med Sci (2004) 0.86
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. Am J Hematol (2013) 0.86
Activation of MAPK and CREB by GM1 induces survival of RGCs in the retina with axotomized nerve. Invest Ophthalmol Vis Sci (2003) 0.86
Muscle insulin resistance resulting from impaired microvascular insulin sensitivity in Sprague Dawley rats. Cardiovasc Res (2013) 0.86
Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling. Endocrinology (2008) 0.85
Vascular and metabolic effects of candesartan: insights from therapeutic interventions. J Hypertens Suppl (2006) 0.85
Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo. Am J Physiol Endocrinol Metab (2013) 0.85
Regulation of haemolysin (VvhA) production by ferric uptake regulator (Fur) in Vibrio vulnificus: repression of vvhA transcription by Fur and proteolysis of VvhA by Fur-repressive exoproteases. Mol Microbiol (2013) 0.84
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients. Leuk Lymphoma (2015) 0.83
Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors. Am J Ther (2009) 0.82
GLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle. Am J Physiol Endocrinol Metab (2013) 0.82
N-Acetylcysteine infusion does not affect glucose disposal during prolonged moderate-intensity exercise in humans. J Physiol (2010) 0.81
Nutritive blood flow as an essential element supporting muscle anabolism. Curr Opin Clin Nutr Metab Care (2006) 0.81
Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle. Br J Pharmacol (2005) 0.81
Brachial-to-radial SBP amplification: implications of age and estimated central blood pressure from radial tonometry. J Hypertens (2015) 0.81
Back pain secondary to Brucella spondylitis in the lumbar region. Ann Rehabil Med (2012) 0.80
Microvascular contributions to insulin resistance. Diabetes (2013) 0.80
Nutritive blood flow improves interstitial glucose and lactate exchange in perfused rat hindlimb. Am J Physiol Heart Circ Physiol (2002) 0.80
Identification and characterization of a novel serine protease, VvpS, that contains two functional domains and is essential for autolysis of Vibrio vulnificus. J Bacteriol (2011) 0.80
Sonographically guided alcohol injection in painful stump neuroma. Ann Rehabil Med (2012) 0.79
Adiponectin opposes endothelin-1-mediated vasoconstriction in the perfused rat hindlimb. Am J Physiol Heart Circ Physiol (2011) 0.79
VvpM, an extracellular metalloprotease of Vibrio vulnificus, induces apoptotic death of human cells. J Microbiol (2014) 0.79
Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp Mol Med (2005) 0.79
Contrast-enhanced ultrasound measurement of microvascular perfusion relevant to nutrient and hormone delivery in skeletal muscle: a model study in vitro. Microvasc Res (2007) 0.79
Insulin and contraction increase nutritive blood flow in rat muscle in vivo determined by microdialysis of L-[14C]glucose. J Physiol (2007) 0.78
Acute effects of wortmannin on insulin's hemodynamic and metabolic actions in vivo. Am J Physiol Endocrinol Metab (2006) 0.78
Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes. Eur J Haematol (2009) 0.78
A vascular mechanism for high-sodium-induced insulin resistance in rats. Diabetologia (2014) 0.77
Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance. J Physiol (2015) 0.77
Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle. Drug Test Anal (2013) 0.77
Last word on Point:Counterpoint: There is/is not capillary recruitment in active skeletal muscle during exercise. J Appl Physiol (1985) (2008) 0.77
Axially symmetric semi-infinite domain models of microdialysis and their application to the determination of nutritive flow in rat muscle. J Physiol (2004) 0.77
Microvascular flow routes in muscle controlled by vasoconstrictors. Microvasc Res (2005) 0.76
Potential for endothelin-1-mediated impairment of contractile activity in hypertension. Clin Exp Pharmacol Physiol (2007) 0.76
Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis. Endocr Pract (2008) 0.76
Dexamethasone inhibits transforming growth factor-beta receptor (Tbeta R) messenger RNA expression in hamster preantral follicles: possible association with NF-YA. Biol Reprod (2003) 0.76
VvpM induces human cell death via multifarious modes including necroptosis and autophagy. J Microbiol Biotechnol (2015) 0.76
Barriers to the management of Diabetes Mellitus - is there a future role for Laser Doppler Flowmetry? Australas Med J (2012) 0.75
T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo. Br J Pharmacol (2003) 0.75
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy. Int J Hematol (2013) 0.75